Danny L. Dearen
CIK: 0001756438
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Dearen Danny L.
Dearen Danny L. (SEC CIK 0001756438) files insider reports with the SEC as Director of Beta Bionics, Inc. (BBNX) and Director of InspireMD, Inc. (NSPR).
Signal8 holds 6 ownership filings by Dearen Danny L. (2 Form 3, 4 Form 4), filed between Jan 29, 2025 and May 26, 2026. Those filings report 4 transactions, from Mar 15, 2025 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dearen Danny L.'s filings is in IRVINE, CA.
Recent filings by Dearen Danny L.
Other insiders filing for Beta Bionics, Inc. (BBNX)
- Mensinger Mike, Chief Product Officer
- Hopman Mark, Chief Commercial Officer
- Jones Christy, Director
- Saint Sean, President & CEO
- Russell Steven Jon, Chief Medical Officer
- Feider Stephen, Chief Financial Officer